All lobbying filings

Capitol Counsel LLC

Capitol Counsel LLC filed a Q1 report for Ipsen Biopharmaceuticals, Inc. on April 21, 2025, reporting $30,000 in lobbying income.

Lobbying for Ipsen Biopharmaceuticals, Inc. · Biopharmaceutical company.

As filed: CAPITOL COUNSEL LLC for IPSEN BIOPHARMACEUTICALS, INC.

All filings by Capitol Counsel LLC · Everything Ipsen Biopharmaceuticals, Inc. has reported

Filing · LD-2 quarterly report Q1 report

Reporting period

1st Quarter 2025

Jan 1 - Mar 31 · Posted Apr 21, 2025

Income

$30,000

What the client paid this registrant for the period.

Client based in

Massachusetts

Official filing document

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Medicare/Medicaid

Ensure Medicare beneficiary access to Medicare covered prescription drugs and enable beneficiaries to spread cost-sharing requirements, including monitor implementation of related provisions in the Inflation Reduction Act, P.L. 117-169.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.